Literature DB >> 18592727

[Fighting heart attacks and atherosclerosis: a therapeutical challenge].

P-F Keller1, Vincent Barthassat, F Scherrer-Burri, Grégoire Lagger, Sebastian Carballo.   

Abstract

Myocardial infarction is a frequent, serious and recurrent complication of a chronic disease: atherosclerosis. Therapeutic advances have improved the clinical outcome of affected patients and have shortened the hospital length of stay. However, to decrease the recurrence of cardiovascular events, it is essential to increase adherence to therapeutic projects by improving information given to coronary patients during the short initial hospitalization. This can be achieved by using tools that have been developed for the management of chronic disease: therapeutic education and motivational interviews. Moreover, these information tools have to perform well and have to be used at appropriate times to ensure a positive effect on patients.

Entities:  

Mesh:

Year:  2008        PMID: 18592727

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  1 in total

1.  Myristicin regulates proliferation and apoptosis in oxidized low-density lipoprotein-stimulated human vascular smooth muscle cells and human umbilical vein endothelial cells by regulating the PI3K/Akt/NF-κB signalling pathway.

Authors:  Liang Luo; Huiying Liang; Luoying Liu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.